Literature DB >> 8642650

A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation.

D C Bloom1, J M Hill, G Devi-Rao, E K Wagner, L T Feldman, J G Stevens.   

Abstract

Latency-associated transcript (LAT) promoter deletion mutants of herpes simplex virus type 1 have a reduced capacity to reactivate following adrenergic induction in the rabbit eye model. We have mapped a reactivation phenotype within LAT and describe the construction of recombinants in which poly(A) addition sites have been placed at intervals within the LAT region to form truncated LAT transcripts. These mutants localize the induced reactivation phenotype to the 5' end of LAT. To further define this region, we constructed a recombinant containing a 348-bp deletion located 217 bp downstream of the transcription start site of the 8.5-kb LAT. This virus, 17delta348, expresses LAT but exhibits a significantly reduced ability to reactivate following epinephrine iontophoresis into the cornea. Quantitative DNA PCR analysis reveals that 17delta 348 establishes a latent infection within rabbit trigeminal ganglia with the same efficiency as does either the rescuant or wild-type virus. The region deleted in 17delta348 encodes three potential translational initiators (ATGs) which we have mutated and demonstrated to be dispensable for epinephrine-induced reactivation. In addition, three smaller deletions within this region have been constructed and were shown to reactivate at wild-type (parent) frequencies. These studies indicate that an undefined portion of the 348-bp region is required to facilitate induced reactivation. Sequence analysis of this 348-bp region revealed a CpG island which extends into the LAT promoter and which possesses homology to conserved elements within the mouse and human XIST transcript encoded on the X chromosome. Possible implications of these elements in the regulation of LAT expression are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642650      PMCID: PMC190088     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons.

Authors:  J G Stevens; E K Wagner; G B Devi-Rao; M L Cook; L T Feldman
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

2.  Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo.

Authors:  G R Dressler; D L Rock; N W Fraser
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Reactivation of herpetic keratitis by epinephrine in rabbit.

Authors:  P R Laibson; S Kibrick
Journal:  Arch Ophthalmol       Date:  1966-02

5.  Quantitation and kinetics of induced HSV-1 ocular shedding.

Authors:  J M Hill; J B Dudley; Y Shimomura; H E Kaufman
Journal:  Curr Eye Res       Date:  1986-03       Impact factor: 2.424

6.  Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo.

Authors:  D C Bloom; G B Devi-Rao; J M Hill; J G Stevens; E K Wagner
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Methylation of the viral genome in an in vitro model of herpes simplex virus latency.

Authors:  H Youssoufian; S M Hammer; M S Hirsch; C Mulder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  5-Azacytidine-induced reactivation of a herpes simplex thymidine kinase gene.

Authors:  D W Clough; L M Kunkel; R L Davidson
Journal:  Science       Date:  1982-04-02       Impact factor: 47.728

9.  Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent.

Authors:  R L Thompson; J G Stevens
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

10.  Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea.

Authors:  B S Kwon; L P Gangarosa; K D Burch; J deBack; J M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-09       Impact factor: 4.799

View more
  60 in total

1.  Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region.

Authors:  H Berthomme; J Thomas; P Texier; A Epstein; L T Feldman
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  The stable 2.0-kilobase intron of the herpes simplex virus type 1 latency-associated transcript does not function as an antisense repressor of ICP0 in nonneuronal cells.

Authors:  Edward A Burton; Chang-Sook Hong; Joseph C Glorioso
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

4.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice.

Authors:  Anne M Gussow; Nicole V Giordani; Robert K Tran; Yumi Imai; Dacia L Kwiatkowski; Glenn F Rall; Todd P Margolis; David C Bloom
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription.

Authors:  Nicole J Kubat; Antonio L Amelio; Nicole V Giordani; David C Bloom
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Deacetylation of the herpes simplex virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant.

Authors:  Antonio L Amelio; Nicole V Giordani; Nicole J Kubat; Jerome E O'neil; David C Bloom
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes.

Authors:  K Wang; L Pesnicak; S E Straus
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

9.  Deletion of Herpes Simplex Virus 1 MicroRNAs miR-H1 and miR-H6 Impairs Reactivation.

Authors:  Enrico R Barrozo; Sanae Nakayama; Pankaj Singh; Emilia A H Vanni; Ann M Arvin; Donna M Neumann; David C Bloom
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

10.  Herpes Simplex Virus 1 Strains 17syn + and KOS(M) Differ Greatly in Their Ability To Reactivate from Human Neurons In Vitro.

Authors:  Tristan R Grams; Terri G Edwards; David C Bloom
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.